Thomson Announces Thomson Pharma; Powerful New Research Tool For The Pharmaceutical And Biotechnology Industries

PHILADELPHIA and LONDON, Nov. 16 /PRNewswire-FirstCall/ -- In anticipation of its launch at the annual Online Information Exhibition (London) in December 2004, The Thomson Corporation Toronto announced the introduction of its powerful new integrated research solution, Thomson Pharma(SM) (http://www.thomsonpharma.com/). Thomson Pharma brings an indispensable information solution to the workflow of the drug discovery and development process, providing research tools that fulfill the information needs of professionals working at all stages of the drug development pipeline. Conceived and designed based on customer feedback, Thomson Pharma provides researchers and other professionals in the fields of biology, chemistry, licensing, business development and competitive intelligence with the cutting-edge tools needed to make better decisions faster. Full commercial launch of Thomson Pharma is expected in January 2005.

Thomson Pharma integrates trusted information from Thomson Scientific, with critical content from other information businesses across Thomson including content from its Financial, Healthcare and Legal and Regulatory groups. This integration will provide scientific researchers and other professionals with the most complete pharmaceutical information source available on the market today. The core Thomson Pharma content areas include drug information, intellectual property data, literature and news, company data, chemical information, sequence data and drug target information, enhanced with value-added content resources and powerful search tools.

Thomson Pharma provides content derived from well-known legacy products such as Investigational Drugs Database (IDdb), Derwent World Patents Index(R), Delphion(R), Web of Science(R), Drugdex(R), and many more.

At the 2004 Thomson Scientific North America Customer Forum held October 25-26 in Philadelphia, Clifford Kalb, Vice President of Life Sciences, Wood MacKenzie, Inc., spoke about the role of information in the pharmaceutical industry. He stated, "Having the ability to access the right information at the right time reduces uncertainty in the decision making process, by allowing senior management to apply the right information to those decisions."

Thomson Pharma was developed to address the immediate and future needs of the pharmaceutical and information industry. Throughout the development process customer feedback was a key factor. Many of the new functionalities and reports were developed in direct response to 11,000 customer comments, ranging from large pharmaceutical organizations to start-up biotechnology companies, collected over eight months in 2004.

There are many disparate information sources used by clinical researchers, scientists, competitive intelligence professionals, licensing and business development professionals, and sales and marketing executives in the drug discovery pipeline. To date, finding the necessary information and then using it to make decisions has been time and labor intensive. David Brown, former president & CEO of Cellzome, Inc., stated, "It is a great challenge for very large companies to share information across many levels. Developing an information architecture that helps this flow would be invaluable." Thomson Pharma is the single integrated source of information that allows users to share information, customize home pages and reports and offer other flexible options to enhance communications and expedite critical decision making.

"It is this type of feedback that drove the development of Thomson Pharma, and we continue to maintain our work with customers to evolve the product. We accepted the challenge to create a resource that would break down the information barriers to the business-critical content necessary for our customers to maintain a competitive advantage," said Ian Tarr, Executive Vice President, Pharma & Chemical Markets, Thomson Scientific. "Thomson Pharma will provide professionals worldwide with unparalleled access to pharmaceutical-related information and news. Thomson offers best-in-class content, providing access to the most complete data available and the most efficient technologies essential for small and large companies alike. It is the paradigm of what can be achieved when high-quality content and the most progressive technologies are merged."

For more information about Thomson Pharma, visit http://www.thomsonpharma.com/.

About The Thomson Corporation

The Thomson Corporation (http://www.thomson.com/), with 2003 revenues from continuing operations of $7.44 billion, is a global leader in providing integrated information solutions to business and professional customers. Thomson provides value-added information, software tools and applications to more than 20 million users in the fields of law, tax, accounting, financial services, higher education, reference information, corporate training and assessment, scientific research and healthcare. With operational headquarters in Stamford, Conn., Thomson has approximately 38,000 employees and provides services in approximately 130 countries. The Corporation's common shares are listed on the New York and Toronto stock exchanges Toronto.

Thomson Scientific (a Thomson business) information solutions can be found at http://www.thomson.com/scientific and include, ISI Web of Knowledge(SM) - facilitating discovery by offering seamless navigation to high-quality, multidisciplinary journal (Web of Science(R)), patent (Derwent World Patents Index(R)), and Web content, evaluation tools, and bibliographic management products (EndNote(R)); Thomson Pharma(SM) - an integrated information solution for the pharmaceutical and biotechnology markets; Delphion(R) - providing access to full-text patent documents from the world's leading patent authorities; Techstreet - offering a wide variety of engineering codes and standards; and BIOSIS Previews(R) - the world's most comprehensive reference database for life science research.

Thomson Scientific

CONTACT: Rodney Yancey, Manager, Corporate Communications, ThomsonScientific, +1-215-386-0100 extension 1396 or rodney.yancey@thomson.com; orRobert Doody of Dorland Global Health Communications, +1-215-928-2183 orrdoody@dorland.com, for Thomson Scientific

Back to news